PL343602A1 - Adjuvant-containing vaccines - Google Patents

Adjuvant-containing vaccines

Info

Publication number
PL343602A1
PL343602A1 PL99343602A PL34360299A PL343602A1 PL 343602 A1 PL343602 A1 PL 343602A1 PL 99343602 A PL99343602 A PL 99343602A PL 34360299 A PL34360299 A PL 34360299A PL 343602 A1 PL343602 A1 PL 343602A1
Authority
PL
Poland
Prior art keywords
adjuvant
containing vaccines
vaccines
Prior art date
Application number
PL99343602A
Other versions
PL194348B1 (en
Inventor
Jean-Christophe Franc Audonnet
Jules Maarten Minke
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9525029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL343602(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Sas filed Critical Merial Sas
Publication of PL343602A1 publication Critical patent/PL343602A1/en
Publication of PL194348B1 publication Critical patent/PL194348B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL99343602A 1998-04-03 1999-03-22 Adjuvant-containing vaccines PL194348B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804409A FR2776928B1 (en) 1998-04-03 1998-04-03 ADJUVATED DNA VACCINES
PCT/FR1999/000666 WO1999051269A1 (en) 1998-04-03 1999-03-22 Adjuvant-containing vaccines

Publications (2)

Publication Number Publication Date
PL343602A1 true PL343602A1 (en) 2001-08-27
PL194348B1 PL194348B1 (en) 2007-05-31

Family

ID=9525029

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343602A PL194348B1 (en) 1998-04-03 1999-03-22 Adjuvant-containing vaccines

Country Status (17)

Country Link
US (1) US7163926B1 (en)
EP (1) EP1066055B1 (en)
JP (1) JP2002510651A (en)
AR (1) AR037062A1 (en)
AT (1) ATE353670T1 (en)
AU (1) AU744964B2 (en)
BR (1) BR9909342A (en)
CA (1) CA2327389C (en)
CY (1) CY1108013T1 (en)
DE (1) DE69935136T2 (en)
DK (1) DK1066055T3 (en)
ES (1) ES2283105T3 (en)
FR (1) FR2776928B1 (en)
PL (1) PL194348B1 (en)
PT (1) PT1066055E (en)
WO (1) WO1999051269A1 (en)
ZA (1) ZA992478B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804026B1 (en) * 2000-01-21 2004-06-11 Merial Sas VACCINATION AGAINST HERPESVIROSE CANINE AND VACCINES
US6551598B2 (en) 2000-01-21 2003-04-22 Merial Vaccination against canine herpesvirosis and vaccines therefor
CN1638780A (en) * 2001-12-14 2005-07-13 遗传电子公司 Method for particle-assisted polynucleotide immunization using pulsed electric fields
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
UA100370C2 (en) 2006-12-11 2012-12-25 Мериал Лимитед METHOD OF VACCINATION OF BIRDS AGAINST SALMONELL
CL2008001806A1 (en) * 2007-06-20 2008-09-05 Wyeth Corp COMPOSITION OF VACCINE IN EMULSION WATER IN OIL THAT INCLUDES AN ANTIGEN AND AN ADJUSTER IN THE WATERPROOF PHASE; AND METHOD OF ELABORATION.
GB0805356D0 (en) * 2008-03-25 2008-04-30 Isis Innovation Vaccine adjuvant composition
US8603808B2 (en) 2008-05-08 2013-12-10 Merial Limited Leishmania vaccine using sand fly salivary immunogen
AP3334A (en) * 2008-10-24 2015-07-31 Univ California Vaccine against african horse sickness virus
BR112014001287B1 (en) 2011-07-20 2020-12-08 Centre National De La Recherche Scientifique feline leukemia virus recombinant vaccine containing optimized feline leukemia virus envelope gene
US20130177591A1 (en) 2012-01-10 2013-07-11 Merial Limited Lipid Based Adjuvants for DNA Plasmids
ES2711878T3 (en) 2012-03-20 2019-05-08 Merial Inc Vaccine against recombinant equine herpes 1 virus containing mutated glycoprotein C and uses thereof
KR102208844B1 (en) 2012-08-30 2021-01-27 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
LT3471760T (en) 2016-06-17 2025-02-25 Boehringer Ingelheim Vetmedica Gmbh NEW IMMUNOGENIC PREPARATIONS CONTAINING LINEAR OR BRANCHED POLYACRYLIC ACID POLYMERS ADJUVANTS
JP2023532878A (en) * 2020-07-07 2023-08-01 アミリス，インコーポレイティド Vaccine adjuvants and methods of synthesizing and using them
CN114272368A (en) * 2021-12-16 2022-04-05 成都博宠生物科技有限公司 A kind of swine fever and porcine pseudorabies dual vaccine and its preparation method and application

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
ZA881694B (en) * 1987-03-17 1988-09-06 Akzo N.V. Adjuvant mixture
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
EP0532833A1 (en) * 1991-05-28 1993-03-24 Miles Inc. Vaccine for equine rhinopneumonitis
ATE259417T1 (en) * 1992-06-01 2004-02-15 Univ Melbourne IMMUNOLOGICAL METHOD FOR THE DETECTION OF EQUINE HERPES VIRUS TYPE 1 AND 4 GLYCOPROTEIN G ANTIBODIES
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
BE1008977A5 (en) * 1994-12-27 1996-10-01 Solvay Adjuvants for vaccines.
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) * 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
FR2751226B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST HORSE PATHOLOGIES
GB9623051D0 (en) * 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
WO1998056931A1 (en) * 1997-06-11 1998-12-17 Institut Pasteur Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
AU8392898A (en) * 1997-07-14 1999-02-10 Powerject Vaccines, Inc. Method of dna vaccination using dna encoding antigen and encoding il6
GB9726398D0 (en) * 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof

Also Published As

Publication number Publication date
DE69935136T2 (en) 2007-11-29
EP1066055B1 (en) 2007-02-14
CA2327389A1 (en) 1999-10-14
BR9909342A (en) 2000-12-12
ES2283105T3 (en) 2007-10-16
AU744964B2 (en) 2002-03-07
PT1066055E (en) 2007-05-31
WO1999051269A1 (en) 1999-10-14
ZA992478B (en) 2000-10-10
FR2776928A1 (en) 1999-10-08
DK1066055T3 (en) 2007-06-11
ATE353670T1 (en) 2007-03-15
FR2776928B1 (en) 2000-06-23
CY1108013T1 (en) 2013-09-04
AU2844899A (en) 1999-10-25
JP2002510651A (en) 2002-04-09
DE69935136D1 (en) 2007-03-29
CA2327389C (en) 2011-06-14
AR037062A1 (en) 2004-10-20
EP1066055A1 (en) 2001-01-10
US7163926B1 (en) 2007-01-16
PL194348B1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
IL140094A0 (en) Vaccine
HUP0105392A3 (en) Enhanced vaccines
ZA992478B (en) Adjuvant-containing dna vaccines.
GB9822714D0 (en) Vaccines
IL139467A0 (en) Vaccine
HUP0101652A3 (en) Hepatitis vaccine
ZA982763B (en) Vaccines
GB9820956D0 (en) Vaccine
GB9807805D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9822712D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9805961D0 (en) Vaccine
GB9802543D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9805962D0 (en) Vaccine
GB9809958D0 (en) Vaccine
GB9806765D0 (en) Vaccine